Janux Therapeutics (JANX) PT Lowered to $23 at Evercore ISI

April 10, 2026 3:15 PM

Evercore ISI analyst Jonathan Miller lowered the price target on Janux Therapeutics (NASDAQ: JANX) to $23.00 (from $25.00) while maintaining a Outperform rating.

No results found